"The greatest wealth is health."         - Virgil

      Advertisement

Our Experts answered these questions:

My wife has arthritis,quite severe. if she sustains a bruise or a cut the results last for weeks or even months. she bruises badly with the slightest...
I was up last night having to use the bathroom with diarrhea for about an hour. This morning i woke up and i felt like i was going to throw up and i h...
Do You Have a Health Question? Ask Our Experts!

Vaccine Safety

Menu

• Home
• Ask our Experts about XELODA
• Ask Community about XELODA
• XELODA Usage
• Patients Wiki
• Share Your Health Story
• Take a Survey
• Health Blogs

More Resources

• Federal Food and Drug Administration
• Hospital Quality Reports
• Home Care Quality

XELODA Safety Questions, XELODA Answers

More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about XELODA. Our extensive database of XELODA adverse events and XELODA warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements

Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about XELODA

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet

Type your question here

 letters left

XELODA Safety Reports

Total XELODA reports: 523.
XELODA FDA safety alerts: 2001 .
Reported deaths: 156    Reported hospitalizations: 225.
Take XELODA Side Effects Survey or Share Your XELODA Story. XELODA Usage.

Showing 1-75 of 523 Next >

Consumer or non-health professional from SWITZERLAND reported XELODA problem on Mar 09, 2007. Female patient, 59 years of age, was diagnosed with breast cancer female, metastases to bone and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: osteonecrosis. XELODA dosage: unknown. During the same period patient was treated with ZOMETA. Patient recovered.

XELODA problem was reported by a Pharmacist from SOUTH AFRICA on Mar 09, 2007. Male patient, 73 years of age, was diagnosed with hypotension and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: balanitis, palmar-plantar erythrodysaesthesia syndrome. XELODA dosage: PATIENT RECEIVED 1500 MG IN THE MORNING AND 1000 MG IN THE EVENING.. During the same period patient was treated with EFFORTIL. Patient recovered.

Consumer or non-health professional from SWITZERLAND reported XELODA problem on Mar 12, 2007. Male patient, 46 years of age, was diagnosed with prophylaxis and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: intestinal ischaemia, large intestine perforation. XELODA dosage: unknown. During the same period patient was treated with ANZEMET, TAXOTERE, MEPHAMESONE, CISPLATIN, EMEND. Patient was hospitalized. Patient recovered.

XELODA problem was reported by a Physician from UNITED STATES on Mar 12, 2007. Male patient, 58 years of age, weighting 170.0 lb, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: stevens-johnson syndrome, vasculitis. XELODA dosage: unknown. During the same period patient was treated with OXALIPLATIN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from CHINA reported XELODA problem on Mar 09, 2007. Male patient, 69 years of age, was diagnosed with small intestine carcinoma and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: cerebral infarction. XELODA dosage: unknown. Patient recovered.

XELODA problem was reported by a Pharmacist from UNITED KINGDOM on Mar 14, 2007. Male patient, 72 years of age, weighting 136.7 lb, was diagnosed with colon cancer and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: diarrhoea, renal failure, vomiting. XELODA dosage: unknown. Patient was hospitalized. Patient died.

Physician from UNITED STATES reported XELODA problem on Mar 12, 2007. Male patient, 90 years of age, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: colon cancer metastatic, dysarthria, fall, gait disturbance, somnolence, transient ischaemic attack. XELODA dosage: unknown. Patient died on 03/08/2007.

XELODA problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 09, 2007. Male patient, weighting 80.03 lb, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: colon cancer metastatic, coma, haemorrhage, overdose, rash macular. XELODA dosage: unknown. During the same period patient was treated with ASPIRIN. Patient was hospitalized. Patient died on 07/17/2005.

Physician from FRANCE reported XELODA problem on Mar 15, 2007. Female patient, 60 years of age, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: dehydration, diarrhoea, renal failure, vomiting. XELODA dosage: THE DOSE WAS REPORTED AS ^1250 MG/M2 TWICE^. THE FIRST CYCLE HAD A WEEK OF DISCONTINUATION FOLLOWIN+. During the same period patient was treated with TAMOXIFEN CITRATE, TAXOTERE. Patient died.

XELODA problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 16, 2007. Male patient, 36 years of age, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: chills, hypothermia, neutropenia. XELODA dosage: unknown. During the same period patient was treated with IRINOTECAN. Patient recovered.

Physician from ITALY reported XELODA problem on Mar 22, 2007. Female patient, 71 years of age, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: blood glucose increased. XELODA dosage: STRENGHT REPORTED AS UNK MG.. Patient was hospitalized. Patient recovered.

XELODA problem was reported by a Physician from NEW ZEALAND on Mar 21, 2007. Female patient, 52 years of age, weighting 175.0 lb, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: cardiogenic shock, cardiotoxicity. XELODA dosage: unknown. Patient recovered.

Physician from GERMANY reported XELODA problem on Mar 22, 2007. Female patient, 79 years of age, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: anorexia, ascites, depression, disease progression, gastric polyps, hyperthyroidism, hypoglycaemia, insulinoma. XELODA dosage: unknown. During the same period patient was treated with HERCEPTIN, NAVELBINE, AROMASIN, TAMOXIFEN CITRATE, TAXOL, BIPHOSPHONATE, AREDIA, ARIMIDEX. Patient was hospitalized. Patient recovered.

XELODA problem was reported by a Physician from UNITED STATES on Apr 02, 2007. Female patient, weighting 157.0 lb, was diagnosed with colon cancer and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: anorexia, condition aggravated, nausea, parkinson's disease. XELODA dosage: 2000MG BID PO. During the same period patient was treated with LIPITOR, LEVOXYL, ATIVAN, ZOFRAN, PROCHLORPERAZINE. Patient recovered.

Consumer or non-health professional from CANADA reported XELODA problem on Mar 26, 2007. Female patient, 58 years of age, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: insomnia, oedema peripheral, pulmonary oedema. XELODA dosage: unknown. Patient was hospitalized. Patient died on 11/09/2006.

XELODA problem was reported by a Physician from FRANCE on Mar 27, 2007. Male patient, 68 years of age, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: visual disturbance. XELODA dosage: unknown. Patient recovered.

Physician from JAPAN reported XELODA problem on Mar 28, 2007. Female patient, 50 years of age, was diagnosed with breast cancer metastatic and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: inappropriate antidiuretic hormone secretion. XELODA dosage: unknown. Patient died.

XELODA problem was reported by a Physician from GERMANY on Mar 30, 2007. Male patient, weighting 136.7 lb, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: diarrhoea, inflammation, mucosal inflammation, pyrexia, shock. XELODA dosage: 2X1000 MG/M2 FROM DAYS 1 TO 14 OF A TWO WEEK CYCLE. (CYCLE 1).. During the same period patient was treated with OXALIPLATIN, AVASTIN. Patient was hospitalized. Patient recovered.

Physician from RUSSIAN FEDERATION reported XELODA problem on Mar 30, 2007. Male patient, 65 years of age, was diagnosed with colon cancer metastatic and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: angina pectoris, intestinal obstruction. XELODA dosage: unknown. Patient died.

XELODA problem was reported by a Physician from ITALY on Mar 30, 2007. Female patient, 71 years of age, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, diarrhoea. XELODA dosage: STRENGHT REPORTED AS UNK MG.. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported XELODA problem on Mar 29, 2007. Male patient, 65 years of age, weighting 159.0 lb, was diagnosed with colon cancer and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: asthenia, cardiac arrest, diarrhoea, hepatitis, intestinal ischaemia, large intestine perforation, mucosal inflammation, rhabdomyolysis, sepsis. XELODA dosage: unknown. During the same period patient was treated with AVASTIN, OXALIPLATIN, ZOCOR, LEVOFLOXACIN, FLAGYL. Patient was hospitalized. Patient died on 01/02/2007.

XELODA problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 04, 2007. Female patient, 84 years of age, weighting 110.0 lb, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: atrioventricular block, dry skin, dyspnoea exertional, myocardial infarction, pain, palmar-plantar erythrodysaesthesia syndrome, pruritus. XELODA dosage: THE PATIENT WAS GIVEN A PRESCRIPTION FOR XELODA 1500 MG TWICE DAILY FOR 14 DAYS. SHE COMPLETED 4 C+. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported XELODA problem on Apr 02, 2007. Male patient, 65 years of age, weighting 159.0 lb, was diagnosed with colon cancer and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: asthenia, cardiac arrest, diarrhoea, hepatitis, intestinal ischaemia, large intestine perforation, mucosal inflammation, rhabdomyolysis, shock. XELODA dosage: unknown. During the same period patient was treated with AVASTIN, OXALIPLATIN, ZOCOR, LEVOFLOXACIN, FLAGYL. Patient was hospitalized. Patient died on 01/02/2007.

XELODA problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 13, 2007. Female patient, weighting 114.6 lb, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: asthenia, melaena. XELODA dosage: 54000 MG. During the same period patient was treated with CAMPTOSAR, ASPIRIN, FISH OIL, LASIX, LIPITOR, VITAMIN WITH IRON, TOPROL. Patient was hospitalized. Patient recovered.

Pharmacist from FRANCE reported XELODA problem on Apr 05, 2007. Female patient, 56 years of age, was diagnosed with breast cancer and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: polydipsia. XELODA dosage: unknown. Patient recovered.

XELODA problem was reported by a Physician from NEW ZEALAND on Apr 05, 2007. Female patient was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: portal vein thrombosis. XELODA dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from POLAND reported XELODA problem on Apr 03, 2007. Female patient, 58 years of age, was diagnosed with breast cancer and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: diarrhoea, enteritis, multi-organ failure, oesophagitis, palmar-plantar erythrodysaesthesia syndrome, pharyngeal inflammation. XELODA dosage: unknown. Patient was hospitalized. Patient died.

XELODA problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 05, 2007. Male patient, 85 years of age, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: cardiac disorder, cardiac failure congestive, chest pain, coronary artery disease. XELODA dosage: unknown. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported XELODA problem on Apr 13, 2007. Male patient was diagnosed with neoplasm malignant and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident. XELODA dosage: 1500MG 2X/DAY X 14 DAYS PO. Patient recovered.

XELODA problem was reported by a Pharmacist from UNITED STATES on Apr 13, 2007. Female patient was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: diarrhoea. XELODA dosage: 500MG 2 - BID PO MID -JAN. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported XELODA problem on Apr 11, 2007. Male patient, weighting 170.0 lb, was diagnosed with colon cancer metastatic and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: stevens-johnson syndrome, vasculitis. XELODA dosage: unknown. During the same period patient was treated with OXALIPLATIN. Patient was hospitalized. Patient recovered.

XELODA problem was reported by a Physician from FRANCE on Mar 27, 2007. Male patient, 68 years of age, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: visual disturbance. XELODA dosage: unknown. Patient recovered.

Physician from SWEDEN reported XELODA problem on Apr 12, 2007. Male patient, 51 years of age, weighting 169.8 lb, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: cardiac failure. XELODA dosage: unknown. During the same period patient was treated with ERLOTINIB, GEMCITABINE, OXALIPLATIN, NOVOMIX, CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE. Patient died on 12/24/2006.

XELODA problem was reported by a Consumer or non-health professional from SPAIN on Apr 12, 2007. Male patient, 60 years of age, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: oesophagitis, vomiting. XELODA dosage: unknown. During the same period patient was treated with GEMZAR, CAPOTEN, COLCHIMAX, OMEPRAZOLE, DIPYRONE, EMPORTAL, ONDANSETRON. Patient was hospitalized. Patient recovered.

Physician from GERMANY reported XELODA problem on Apr 13, 2007. Female patient, 34 years of age, weighting 163.1 lb, was diagnosed with breast cancer and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: chest discomfort, hyperventilation, pharyngeal mass. XELODA dosage: unknown. Patient recovered.

XELODA problem was reported by a Physician from CHILE on Apr 11, 2007. Female patient, 65 years of age, weighting 123.5 lb, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: asthenia, cardiogenic shock, dyspnoea, embolism. XELODA dosage: unknown. Patient died on 03/30/2007.

Consumer or non-health professional from FRANCE reported XELODA problem on Apr 13, 2007. Female patient, 71 years of age, was diagnosed with rectal cancer and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: diarrhoea, hypokalaemia, hypoproteinaemia, vomiting, weight decreased. XELODA dosage: unknown. During the same period patient was treated with ELOXATIN, FOLFOX. Patient recovered.

XELODA problem was reported by a Physician from FINLAND on Apr 13, 2007. Female patient, 76 years of age, weighting 176.4 lb, was diagnosed with rheumatoid arthritis and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: bacterial sepsis, c-reactive protein increased, chest pain, coronary artery thrombosis, deep vein thrombosis, depressed level of consciousness, diarrhoea, haematochezia, leukopenia. XELODA dosage: unknown. During the same period patient was treated with TREXAN, PREDNISONE, OXIKLORIN, LIPCUT, NEXIUM, KALCIPOS, FOLVITE. Patient was hospitalized. Patient died on 12/01/2006.

Consumer or non-health professional from UNITED STATES reported XELODA problem on Apr 23, 2007. Female patient, weighting 114.6 lb, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: adverse event, asthenia, fatigue, melaena. XELODA dosage: 54000 MG. During the same period patient was treated with CAMPTOSAR, ASPIRIN, FISH OIL, LASIX, LIPITOR, VITAMIN WITH IRON, TOPROL. Patient was hospitalized. Patient recovered.

XELODA problem was reported by a Physician from UNITED STATES on Apr 16, 2007. Female patient, 62 years of age, weighting 82.89 lb, was diagnosed with colon cancer and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: clostridium difficile colitis, diarrhoea. XELODA dosage: unknown. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported XELODA problem on Apr 19, 2007. Male patient was diagnosed with colorectal cancer metastatic and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: supraventricular tachycardia. XELODA dosage: unknown. During the same period patient was treated with ELOXATIN, AVASTIN. Patient was hospitalized. Patient recovered.

XELODA problem was reported by a Physician from RUSSIAN FEDERATION on Apr 13, 2007. Male patient, 65 years of age, was diagnosed with colon cancer metastatic and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: angina pectoris, intestinal obstruction, peritonitis. XELODA dosage: unknown. Patient died on 02/12/2007.

Consumer or non-health professional from FRANCE reported XELODA problem on Apr 17, 2007. Female patient, 79 years of age, weighting 94.80 lb, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: glossitis. XELODA dosage: unknown. Patient was hospitalized. Patient recovered.

XELODA problem was reported by a Physician from SWITZERLAND on Apr 18, 2007. Female patient, 77 years of age, was diagnosed with diabetes mellitus and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: prothrombin time prolonged, subdural haematoma. XELODA dosage: unknown. During the same period patient was treated with ASPIRIN, AMARYL, GLUCOPHAGE, COAPROVEL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported XELODA problem on Apr 18, 2007. Female patient was diagnosed with colorectal cancer, hepatic neoplasm malignant and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: disease progression. XELODA dosage: unknown. During the same period patient was treated with ELOXATIN, AVASTIN. Patient died.

XELODA problem was reported by a Consumer or non-health professional from FRANCE on Apr 16, 2007. Male patient, 69 years of age, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: facial palsy. XELODA dosage: unknown. During the same period patient was treated with CISPLATIN, FARMORUBICINE. Patient was hospitalized. Patient recovered.

Physician from CHILE reported XELODA problem on Apr 20, 2007. Female patient, 65 years of age, weighting 123.5 lb, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: asthenia, cardiogenic shock, dyspnoea, embolism, pleural effusion. XELODA dosage: unknown. Patient died on 03/30/2007.

XELODA problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 16, 2007. Male patient, 69 years of age, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: thrombosis. XELODA dosage: unknown. During the same period patient was treated with LENTINAN, GREEN TEA. Patient recovered.

Physician from UNITED STATES reported XELODA problem on Apr 16, 2007. Female patient, 79 years of age, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: optic neuritis. XELODA dosage: unknown. During the same period patient was treated with COMPAZINE. Patient recovered.

XELODA problem was reported by a Health Professional from UNITED STATES on Apr 19, 2007. Male patient, 89 years of age, weighting 140.9 lb, was diagnosed with idiopathic thrombocytopenic purpura and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: diarrhoea, eating disorder, gastritis, idiopathic thrombocytopenic purpura, influenza, oesophagitis, palmar-plantar erythrodysaesthesia syndrome. XELODA dosage: unknown. During the same period patient was treated with PREDNISONE. Patient was hospitalized. Patient recovered.

Physician from FRANCE reported XELODA problem on Apr 23, 2007. Male patient, 68 years of age, weighting 136.7 lb, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: visual acuity reduced. XELODA dosage: unknown. Patient recovered.

XELODA problem was reported by a Health Professional from UNITED STATES on Apr 24, 2007. Male patient was diagnosed with colorectal cancer metastatic and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: supraventricular tachycardia. XELODA dosage: unknown. During the same period patient was treated with ELOXATIN, AVASTIN. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED KINGDOM reported XELODA problem on Apr 25, 2007. Male patient, 72 years of age, weighting 136.7 lb, was diagnosed with colon cancer and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: diarrhoea, renal failure, vomiting. XELODA dosage: unknown. During the same period patient was treated with WARFARIN, ATORVASTATIN CALCIUM, TAMSULOSIN, AMIODARONE, FRUSEMIDE, GLICLAZIDE, OMEPRAZOLE. Patient was hospitalized. Patient died.

XELODA problem was reported by a Physician from IRELAND on Apr 23, 2007. Female patient, 77 years of age, weighting 125.7 lb, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: diarrhoea, neutropenia. XELODA dosage: DOSE: 1000MG/M2.. During the same period patient was treated with NEORECORMON, TENORMIN, LIPITOR, LASIX, SOLPADEINE. Patient was hospitalized. Patient died on 04/04/2007.

Health Professional from UNITED STATES reported XELODA problem on Apr 25, 2007. Female patient, 48 years of age, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: cardiac failure congestive, gastrointestinal disorder, hepatic enzyme increased, pleural effusion, urinary tract infection. XELODA dosage: unknown. During the same period patient was treated with TAXOTERE. Patient died on 04/16/2007.

XELODA problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 24, 2007. Male patient, 81 years of age, was diagnosed with colon cancer and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: asthenia, dehydration, diarrhoea, pericardial effusion, pulmonary oedema. XELODA dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported XELODA problem on May 01, 2007. Female patient, 35 years of age, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: aggression, convulsion, loss of consciousness. XELODA dosage: unknown. Patient recovered.

XELODA problem was reported by a Consumer or non-health professional from GERMANY on May 04, 2007. Female patient, 59 years of age, was diagnosed with thrombosis prophylaxis and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: bundle branch block left, cardiac failure, mitral valve incompetence, myocardial infarction, pancytopenia, pulmonary embolism, tricuspid valve incompetence. XELODA dosage: unknown. During the same period patient was treated with MARCUMAR. Patient was hospitalized. Patient recovered.

Physician from JORDAN reported XELODA problem on May 08, 2007. Male patient, 53 years of age, weighting 147.7 lb, was diagnosed with diabetes mellitus and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: mouth ulceration, mucosal inflammation, palmar-plantar erythrodysaesthesia syndrome, pigmentation disorder. XELODA dosage: unknown. During the same period patient was treated with INSULIN. Patient recovered.

XELODA problem was reported by a Physician from EGYPT on May 08, 2007. Female patient, 55 years of age, was diagnosed with colorectal cancer and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: diarrhoea, iliac artery thrombosis, palmar-plantar erythrodysaesthesia syndrome. XELODA dosage: unknown. During the same period patient was treated with OXALIPLATIN. Patient was hospitalized. Patient died on 05/04/2007.

Physician from AUSTRALIA reported XELODA problem on May 09, 2007. Male patient, 72 years of age, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: diarrhoea, intestinal obstruction, nausea. XELODA dosage: 2500 MG/M2/DAY DAYS 1-14 EVERY 3 WEEKS TOTAL DAILY DOSING AMOUNT (2500 MG/M2) DIVIDED INTO TWO DAIL+. During the same period patient was treated with BEVACIZUMAB, MITOMYCIN. Patient was hospitalized. Patient recovered.

XELODA problem was reported by a Health Professional from SPAIN on May 11, 2007. Female patient, 51 years of age, weighting 145.5 lb, was diagnosed with candidiasis, epilepsy and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: diarrhoea, granulocytopenia, mucosal inflammation, neutropenia. XELODA dosage: unknown. During the same period patient was treated with LOITIN, DURAGESIC, NEOSIDANTOINA, NEURONTIN, PANTECTA. Patient was hospitalized. Patient died on 03/05/2007.

Health Professional from SPAIN reported XELODA problem on May 11, 2007. Female patient, 56 years of age, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: enanthema, genital rash, hyperaesthesia. XELODA dosage: unknown. Patient recovered.

XELODA problem was reported by a Consumer or non-health professional from UNITED STATES on May 11, 2007. Female patient, 75 years of age, was diagnosed with metastases to central nervous system, breast cancer and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: fungaemia, fungal infection, melaena, vomiting. XELODA dosage: unknown. During the same period patient was treated with LAPATINIB. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported XELODA problem on May 15, 2007. Male patient, 47 years of age, weighting 136.7 lb, was diagnosed with rectal cancer and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: impaired healing. XELODA dosage: unknown. During the same period patient was treated with BEVACIZUMAB, OXALIPLATIN. Patient was hospitalized. Patient recovered.

XELODA problem was reported by a Health Professional from UNITED STATES on May 17, 2007. Female patient was diagnosed with breast cancer and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: brain neoplasm. XELODA dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported XELODA problem on May 24, 2007. Female patient, weighting 126.0 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: anorexia, electrocardiogram st-t segment depression, fatigue, infusion related reaction, nausea, no therapeutic response, temperature intolerance, vomiting. XELODA dosage: 1500MG BIDX14DAYS, 7DOFF ORALLY. During the same period patient was treated with PROTONIX, ATIVAN, COMPAZINE, ZOFRAN. Patient was hospitalized. Patient recovered.

XELODA problem was reported by a Physician from POLAND on May 15, 2007. Male patient, 78 years of age, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: gastrointestinal haemorrhage, gastrointestinal mucosal disorder, palmar-plantar erythrodysaesthesia syndrome. XELODA dosage: unknown. Patient was hospitalized. Patient died on 05/14/2007.

Physician from JORDAN reported XELODA problem on May 22, 2007. Male patient, 53 years of age, weighting 147.7 lb, was diagnosed with diabetes mellitus and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: mouth ulceration, mucosal inflammation, palmar-plantar erythrodysaesthesia syndrome, pigmentation disorder. XELODA dosage: unknown. During the same period patient was treated with INSULIN. Patient was hospitalized and became disabled. Patient recovered.

XELODA problem was reported by a Physician from UNITED STATES on May 22, 2007. Female patient, 62 years of age, weighting 82.89 lb, was diagnosed with colon cancer and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: clostridium difficile colitis, diarrhoea. XELODA dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from POLAND reported XELODA problem on May 23, 2007. Female patient, 58 years of age, was diagnosed with breast cancer stage iv and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: diarrhoea, enteritis, multi-organ failure, oesophagitis, palmar-plantar erythrodysaesthesia syndrome, pharyngeal inflammation. XELODA dosage: unknown. Patient was hospitalized. Patient died.

XELODA problem was reported by a Health Professional from UNITED KINGDOM on May 22, 2007. Female patient, 61 years of age, weighting 138.9 lb, was diagnosed with breast cancer, bone pain and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: depression, palmar-plantar erythrodysaesthesia syndrome, suicidal ideation. XELODA dosage: unknown. During the same period patient was treated with NAPROXEN. Patient recovered.

Health Professional from UNITED STATES reported XELODA problem on May 22, 2007. Male patient, 47 years of age, weighting 136.7 lb, was diagnosed with rectal cancer and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: impaired healing. XELODA dosage: FREQUENCY REPORTED AS BID/D1-14/Q3W. DOSE: 750MG/M2 TAKEN TWICE A DAY EVERY 14 DAYS. During the same period patient was treated with BEVACIZUMAB, OXALIPLATIN. Patient was hospitalized. Patient recovered.

XELODA problem was reported by a Physician from GERMANY on May 21, 2007. Female patient, 79 years of age, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: disease progression, hyperthyroidism, insulinoma, spleen scan abnormal, ventricular extrasystoles. XELODA dosage: unknown. During the same period patient was treated with HERCEPTIN, NAVELBINE, AROMASIN, TAMOXIFEN, TAXOL, BIPHOSPHONATE, AREDIA, ARIMIDEX. Patient was hospitalized. Patient recovered.

Physician from EGYPT reported XELODA problem on May 24, 2007. Female patient, 55 years of age, was diagnosed with colorectal cancer and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: diarrhoea, palmar-plantar erythrodysaesthesia syndrome, peripheral ischaemia. XELODA dosage: unknown. During the same period patient was treated with OXALIPLATIN. Patient was hospitalized. Patient died on 05/04/2007.

Showing 1-75 of 523 Next >

Ask Our Patient Community about XELODA
Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions
A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z
This drug has an active FDA Safety Alert
A Abacavir sulfate Abatacept Abilify Acamprosate calcium Accupril Accutane Aceon Aciphex Actiq (fentanyl citrate) Actimmune (aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b) Actonel (risedronate) Actoplus Met (pioglitazone) Actos (pioglitazone) AcuTect (technetium Tc 99m apcitide) Adefovir dipivoxil Advair Diskus(Fluticasone propionate; Salmeterol xinafoate) Adderall (amphetamine salts) Agenerase (amprenavir) Aggrastat (tirofiban) Alamast (pemirolast) Alendronate Alemtuzumab Aleve (naproxen sodium) Alfuzosin Alinia (nitazoxanide) Alimta (pemetrexed) Alitretinoin Almotriptan malate Alosetron hydrochloride Aloxi (palonosetron) Alrex (loteprednol etabonate) Altace (ramipril) Ambien (zolpidem tartrate) Amerge (naratriptan) Aminolevulinic acid Amiodarone Amitiza (lubiprostone) Amnesteem (isotretinoin) Amphadase (hyaluronidase) luronidase) Amphetamine salts Amprenavir Anaprox (naproxen sodium) Angiomax (bivalirudin) Anidulafungin Antagon (ganirelix acetate) Anthelios SX (avobenzone, ecamsule, octocrylene) Apidra (insulin glulisine recombinant) Apokyn (apomorphine) Aprepitant Aprotinin Aptivus (tipranavir) Aranesp (darbepoetin alpha) Arava (leflunomide) Arformoterol Argatroban Aredia (pamidronate) Aripiprazole Arixtra (fondaparinux) Aromasin (exemestane) Arranon (nelarabine) Arsenic trioxide Aspirin Atacand (candesartan cilexetil) Atazanavir sulfate Atomoxetine Avastin (bevacizumab) Avelox (moxifloxacin) Avobenzone, Ecamsule, Octocrylene Avodart (dutasteride) Avonex (interferon beta-1a) Axert (almotriptan malate) Azacitidine Azilect (rasagiline) Azopt (brinzolamide) back to top B Balsalazide disodium Baraclude (entecavir) Benazepril Benicar (olmesartan medoxomil) Bevacizumab Bexarotene Bextra (valdecoxib) Biaxin (clarithromycin) Bimatoprost Bivalirudin Boniva (ibandronate) Bortezomib Brinzolamide Brovana (arformoterol) Bupropion Butisol sodium Byetta (exenatide) back to top C Calfactant Campath (alemtuzumab) Campral (acamprosate calcium) Cancidas (caspofungin) Candesartan cilexetil Capecitabine Capoten (captopril) Captopril Carbamazepine Carbatrol (carbamazepine) Carbrital (pentobarbital and carbromal) Caspofungin Cefditoren pivoxil Cefepime Ceftriaxone Celebrex (celecoxib) Celecoxib Celexa (citalopram hydrobromide) Cetrorelix acetate Cetrotide (cetrorelix acetate) Cetuximab Cevimeline Chantix (varenicline) Cialis (tadalafil) Cilostazol Cinacalcet Cirlesonide Citalopram Claravis (isotretinoin) Clarithromycin Clarinex (desloratadine) Clolar (clofarabine) Clofarabine Clozapine Clozaril (clozapine) Codeine Colazal (balsalazide disodium) Colesevelam Colistimethate Coly-Mycin M (colistimethate) Comtan (entacapone) Concerta (methylphenidate) Conivaptan Cordarone (amiodarone) Crestor (rosuvastatin calcium) Cubicin (daptomycin) Curosurf (poractant alfa) Cylert (pemoline) Cymbalta (duloxetine) Cytotec (misoprostol) back to top D Dacogen (decitabine) Dalfopristin Dalmane (flurazepam) Daptomycin Darbepoetin alpha Darifenacin Darunavir Dasatinib Daytrana (methylphenidate transdermal) DDAVP (desmopressin) DDAVP Nasal Spray (demopressin) DDAVP Rhinal Tube (desmopressin) DDVP (desmopressin Decitabine Deferasirox Definity (perflutren lipid microspheres) Depacon (valproate) Depakene (valproate) Depakote (valproate) Desloratadine Desmopressin Detrol (tolterodine tartrate) terodine tartrate) Dexedrine (dextroamphetamine sulfate) Dexmedetomidine Dexmethylphenidate HCl > Dextroamphetamine sulfate Diastat AcuDial Diazepam rectal gel Didronel (etidronate) Diprivan (propofol) Dofetilide Doral (quazepam) Doxercalcif Drospirenone Duloxetine Duragesic (fentanyl transdermal system) Dutasteride back to top E Eculizumab Edetate disodium Efalizumab Efavirenz Effexor (venlafaxine) Elestat (epinastine) Eletriptan Elidel (pimecrolimus) Ellence (epirubicin) Eloxatin (oxaliplatin) Emend (aprepitant) Emtricitabine Emtriva (emtricitabine) Enablex (darifenacin) Enalapril / Enalaprilat Endrate (edetate disodium) Enfuvirtide Entacapone Entecavir Epinastine Epirubicin Eplerenone Epoetin alfa Epogen (epoetin alfa) Eptifibatide Equetro (carbamazepine) Eraxis (anidulafungin) Erbitux (cetuximab) Ertaczo (sertaconazole) Escitalopram Estazolam Eszopiclone Ethchlorvynol Ethinyl estradiol Etidronate Evoxac (cevimeline) Exelon (rivastigmine tartrate) Exenatide Exjade (deferasirox) Exemestane Extraneal (icodextrin) Ezetimibe Ezetimibe/simvastatin back to top	F Factive (gemifloxacin mesylate) Faslodex (fulvestrant) Felbamate Felbatol (felbamate) Fentanyl buccal tablets Fentanyl citrate Fentanyl transdermal system Fentora (fentanyl buccal tablets) Ferrlecit (sodium ferric gluconate complex) Fleet Accu-Prep (sodium phosphate) Fleet Phospho-Soda (sodium phosphate) Fluoxetine Flurazepam Fluticasone propionate Fluvoxamine Focalin (dexmethylphenidate) Focalin XR (dexmethylphenidate) Fomivirsen Fondaparinux Foradil (formoterol fumarate) Formoterol fumarate Fosamax (alendronate) Fosinopril Frova (frovatriptan succinate) Frovatriptan succinate Fulvestrant Fuzeon (enfuvirtide) G Gabapentin Gabitril (tiagabine) Gadobenate Dimeglumine Gadodiamide Gadolinium Gadopentetate Dimeglumine Gadoteridol Gadoversetamide Galantamine Ganirelix acetate Gatifloxacin Gefitinib Gemifloxacin mesylate Gemtuzumab ozogamicin Geodon (ziprasidone) Gleevec (imatinib mesylate) back to top H Halcion (triazolam) Haldol (haloperidol) Haloperidol Hectorol (doxercalcif) Hepsera (adefovir dipivoxil) Hyaluronidase Hydase (hyaluronidase) Human Secretin back to top I Ibandronate Ibuprofen Icodextrin Iloprost Imatinib mesylate Increlex (Mecasermin [rDNA origin] Infasurf Preservative Free (calfactant) Imitrex (sumatriptan) Innohep (tinzaparin) Inspra (eplerenone) Insulin Aspart recombinant Insulin Detemir recombinant Insulin Glargine recombinant Insulin Glulisine recombinant Intron A (interferon alfa-2b) Integrilin (eptifibatide) ifibatide) Interferon alfa-2b Interferon beta-1a Interferon gamma-1b Invega (paliperidone) Iplex  (mecasermin rinfabate) Iressa (gefitinib) Isotretinoin back to top J Januvia (sitagliptin phosphate) back to top K Kaletra (lopinavir; ritonavir) Kepivance (palifermin) Keppra (levetiracetam) Ketek (telithromycin) Ketotifen fumarate back to top L Lamictal (lamotrigine) Lamotrigine Lantus (insulin glargine recombinant) Leflunomide Lenalidomide Lepirudin recombinant Levalbuterol Levemir (insulin detemir recombinant) Levetiracetam Levitra (vardenafil) Levonorgestrel Levothyroxine sodium Levulan Kerastick (aminolevulinic acid) Lexapro (escitalopram) Lindane Linezolid Lisinopril Lopinavir/ritonavir Lotemax (loteprednol etabonate) Lotensin (benazepril) Loteprednol etabonate Lotronex (alosetron hydrochloride) Lubiprostone Lucentis (ranibizumab) Lumigan (bimatoprost) Lunestra (eszopiclone) Lyrica (pregabalin) back to top M Macugen (pegaptanib) Magnevist (gadopentetate dimeglumine) Maraviroc Mavik (trandolapril) Maxalt (rizatriptan benzoate) Maxipime (cefepime) Mecasermin [rDNA origin] Mecasermin-rinfabate Meloxicam Memantine Metadate CD (methylphenidate HCl) ylphenidate HCl) Methylphenidate HCl Methylphenidate transdermal Mequinol Micafungin Micardis (telmisartan) misartan) Mifeprex (mifepristone) Mifepristone Miglustat Minirin (desmopressin) Mirtazapine Misoprostol Mobic (meloxicam) Modafinil Moexipril Monopril (fosinopril) Moxifloxacin MultiHance (gadobenate dimeglumine) Mycamine (micafungin) Mylotarg (gemtuzumab ozogamicin) back to top N Namenda (memantine) Naprosyn (naproxen) Naproxen Naratriptan Nesiritide recombinant Nateglinide Natrecor (nesiritide recombinant) Nefazodone Nelarabine NeoTect Kit (technetium Tc 99m depreotide) Nesiritide recombinant Neurontin (gabapentin) Nexavar (sorafenib) Nitazoxanide Nitisinone Norelgestromin NovoLog (insulin aspart recombinant) Noxafil (posaconazole) back to top O Olanzapine Olanzapine/fluoxetine Olmesartan medoxomil Omacor (omega-3-acid ethyl esters) Omalizumab Omega-3-acid ethyl esters Omnaris (cirlesonide) Omniscan (gadodiamide) OptiMARK (gadoversetamide) Optison (perflutren protein-type A microspheres) Orencia (abatacept) Orfadin (nitisinone) Orlistat Ortho Evra (norelgestromin; ethinyl estradiol) Oseltamivir phosphate Osmoprep (sodium phosphate) Oxaliplatin Oxcarbazepine back to top P Pacerone (amiodarone) Palifermin Paliperidone Pamidronate Panitumumab Panretin Gel (alitretinoin) Pantoprazole Paricalcitol Paroxetine Paxil (paroxetine) Pegaptanib Pegvisomant Pemetrexed Pemoline Pentobarbital and carbromal Perflutren lipid microspheres Perindopril Phenergan (promethazine) Pimecrolimus Pioglitazone Placidyl (ethchlorvynol) Plan B (levonorgestrel) Pletal (cilostazol)